Source: Scientific Reports. Unidade: IME
Subjects: BIOINFORMÁTICA, NEOPLASIAS PULMONARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NAKATA, Asuka et al. Elevated β-catenin pathway as a novel target for patients with resistance to EGF receptor targeting drugs. Scientific Reports, v. 5, 2015Tradução . . Disponível em: https://doi.org/10.1038/srep13076. Acesso em: 09 nov. 2024.APA
Nakata, A., Yoshida, R., Yamaguchi, R., Yamauchi, M., Tamada, Y., Fujita, A., et al. (2015). Elevated β-catenin pathway as a novel target for patients with resistance to EGF receptor targeting drugs. Scientific Reports, 5. doi:10.1038/srep13076NLM
Nakata A, Yoshida R, Yamaguchi R, Yamauchi M, Tamada Y, Fujita A, Shimamura T, Imoto S, Higuchi T, Nomura M, Kimura T, Nokihara H, Higashiyama M, Kondoh K, Nishihara H, Tojo A, Yano S, Miyano S, Gotoh N. Elevated β-catenin pathway as a novel target for patients with resistance to EGF receptor targeting drugs [Internet]. Scientific Reports. 2015 ; 5[citado 2024 nov. 09 ] Available from: https://doi.org/10.1038/srep13076Vancouver
Nakata A, Yoshida R, Yamaguchi R, Yamauchi M, Tamada Y, Fujita A, Shimamura T, Imoto S, Higuchi T, Nomura M, Kimura T, Nokihara H, Higashiyama M, Kondoh K, Nishihara H, Tojo A, Yano S, Miyano S, Gotoh N. Elevated β-catenin pathway as a novel target for patients with resistance to EGF receptor targeting drugs [Internet]. Scientific Reports. 2015 ; 5[citado 2024 nov. 09 ] Available from: https://doi.org/10.1038/srep13076